Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

[1]  Manjulika Das.  Androgen deprivation therapy for prostate cancer. , 2017, The Lancet. Oncology.

[2]  Tamra E. Meyer,et al.  Sex Steroid Hormone Metabolism in Relation to Risk of Aggressive Prostate Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[3]  M. Stampfer,et al.  Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. , 2014, European urology.

[4]  S. Silvestre,et al.  Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  Jack A. Taylor,et al.  Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent , 2013, The Prostate.

[6]  G. Andriole,et al.  Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial. , 2012, European urology.

[7]  T. Rebbeck,et al.  Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men , 2012, Prostate cancer.

[8]  I. Thompson,et al.  Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[9]  I. Thompson,et al.  Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study , 2011, Cancer Causes & Control.

[10]  I. Thompson,et al.  Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience , 2010, Cancer Prevention Research.

[11]  D. Bauer,et al.  Sex hormones and the risk of incident prostate cancer. , 2010, Urology.

[12]  L. Kolonel,et al.  Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort , 2010, The Prostate.

[13]  A. Hsing,et al.  Androgen and Prostate Cancer: Is the Hypothesis Dead? , 2008, Cancer Epidemiology Biomarkers & Prevention.

[14]  J. Reichardt,et al.  Androgens and the molecular epidemiology of prostate cancer , 2008, Current opinion in endocrinology, diabetes, and obesity.

[15]  A. Roddam,et al.  Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. , 2008, Journal of the National Cancer Institute.

[16]  R. Hayes,et al.  Endogenous sex hormones and the risk of prostate cancer: A prospective study , 2007, International journal of cancer.

[17]  A. Chokkalingam,et al.  Molecular epidemiology of prostate cancer: hormone-related genetic loci. , 2007, Frontiers in bioscience : a journal and virtual library.

[18]  J. Heracek,et al.  Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer , 2007, Steroids.

[19]  V. Mandys,et al.  92 TISSUE AND SERUM LEVELS OF PRINCIPAL ANDROGENS IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER , 2007 .

[20]  A. Whittemore,et al.  Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States) , 2006, Cancer Causes & Control.

[21]  D. English,et al.  Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[22]  W. Willett,et al.  Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  Michael M Lieber,et al.  Journal Review , 2003, International Society of Hair Restoration Surgery.

[24]  C. Huggins,et al.  Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.

[25]  M. Stampfer,et al.  Prospective study of sex hormone levels and risk of prostate cancer. , 1996, Journal of the National Cancer Institute.

[26]  B. Henderson,et al.  Serum androgens and prostate cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  A. Hsing,et al.  Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  M. Pike,et al.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males , 1992, The Lancet.

[29]  Morris Pollard,et al.  Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone , 1982, The Prostate.